Alnylam Pharmaceuticals Inc. (ALNY)

$ 451.73
   
  • Change Today:
    $-9.52
  • 52 Week High: $482.13
  • 52 Week Low: $222.98
  • Currency: US Dollars
  • Shares Issued: 106.30m
  • Volume: 32
  • Market Cap: $48,020m
  • RiskGrade: 247

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 3,499.81 339.60 97.50¢ 463.3 n/a n/a n/a 0.0%
31-Dec-26 4,891.38 790.76 477.46¢ 94.6 0.2 +390% n/a 0.0%
31-Dec-27 6,234.62 1,728.53 959.34¢ 47.1 0.5 +101% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

ALNY Market Data

Currency US Dollars
Share Price $ 451.73
Change Today $ -9.52
% Change -2.06 %
52 Week High $482.13
52 Week Low $222.98
Volume 32
Shares Issued 106.30m
Market Cap $48,020m
RiskGrade 247

What The Brokers Say

Strong Buy 8
Buy 14
Neutral 8
Sell 0
Strong Sell 0
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page